日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The GOG Foundation and EVA/LACOG partnership: a collaborative strategic alliance for clinical trial execution

GOG基金会与EVA/LACOG的合作:临床试验执行方面的战略联盟

Maluf, Fernando; Coleman, Robert L; Nogueira-Rodrigues, Angélica; Monk, Bradley J; Baiocchi, Glauco; Moore, Kathleen N; de Melo, Andréia Cristina; O'Malley, David M; Dal Molin, Graziela Z; Randall, Leslie M; Giornelli, Gonzalo; Slomovitz, Brian; Pareja, René; Pothuri, Bhavana; Eskander, Ramez N; Werutsky, Gustavo; Herzog, Thomas J

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

对于新诊断的高危子宫内膜癌,帕博利珠单抗或安慰剂联合辅助化疗(伴或不伴放疗)可导致错配修复缺陷型肿瘤

Slomovitz, Brian M; Cibula, David; Lv, Weiguo; Ortaç, Fırat; Hietanen, Sakari; Backes, Floor; Kikuchi, Akira; Lorusso, Domenica; Dańska-Bidzińska, Anna; Samouëlian, Vanessa; Barretina-Ginesta, Maria-Pilar; Vulsteke, Christof; Lai, Chyong-Huey; Pothuri, Bhavana; Zhang, Yu; Magallanes-Maciel, Manuel; Amit, Amnon; Guarneri, Valentina; Zagouri, Flora; Bell, Maria; Welz, Julia; Eminowicz, Gemma; Hruda, Martin; Willmott, Lyndsay J; Lichfield, Jasmine; Wang, Wei; Orlowski, Robert; Aktan, Gursel; Gladieff, Laurence; Van Gorp, Toon

Examining the Association of Body Mass Index and Complications When Including Sentinel Lymph Node Biopsy in Minimally Invasive Surgery for Endometrial Intraepithelial Neoplasia

探讨在微创手术治疗子宫内膜上皮内瘤变时,体重指数与前哨淋巴结活检并发症之间的关联

Levin, Gabriel; Ramirez, Pedro T; Wright, Jason D; Slomovitz, Brian M; Gotlieb, Walter H; Siedhoff, Matthew T; Wright, Kelly N; Meyer, Raanan

A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel

一份用通俗易懂的语言总结了接受多斯他利单抗联合卡铂-紫杉醇治疗的子宫内膜癌患者的生存情况的报告。

Powell, Matthew A; Bjørge, Line; Willmott, Lyndsay; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Gropp-Meier, Martina; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Segev, Yakir; Gill, Sarah E; Gennigens, Christine; Sebastianelli, Alexandra; Shahin, Mark S; Pothuri, Bhavana; Monk, Bradley J; Buscema, Joseph; Coleman, Robert L; Slomovitz, Brian M; Ring, Kari L; Herzog, Thomas J; Balas, Morad Marco; Grimshaw, Matthew; Stevens, Shadi; Lai, Dominic W; McCourt, Carolyn; Mirza, Mansoor Raza

A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer"

“多斯利单抗治疗原发性晚期或复发性子宫内膜癌”的简明语言摘要

Mirza, Mansoor R; Chase, Dana M; Slomovitz, Brian M; Christensen, René dePont; Novák, Zoltán; Black, Destin; Gilbert, Lucy; Sharma, Sudarshan; Valabrega, Giorgio; Landrum, Lisa M; Hanker, Lars C; Stuckey, Ashley; Boere, Ingrid; Gold, Michael A; Auranen, Annika; Pothuri, Bhavana; Cibula, David; McCourt, Carolyn; Raspagliesi, Francesco; Shahin, Mark S; Gill, Sarah E; Monk, Bradley J; Buscema, Joseph; Herzog, Thomas J; Copeland, Larry J; Tian, Min; He, Zangdong; Stevens, Shadi; Zografos, Eleftherios; Coleman, Robert L; Powell, Matthew A

Unmet needs and emerging therapeutics in low-grade serous ovarian carcinoma: from chemoresistance to precision medicine

低级别浆液性卵巢癌的未满足需求和新兴疗法:从化疗耐药到精准医疗

Slomovitz, Brian M; Podder, Vivek; Crane, Erin; Brown, Jubilee

Comprehensive management of vulvovaginal cancers

外阴阴道癌的综合治疗

Nogueira-Rodrigues, Angélica; Oonk, Maaike H M; Lorusso, Domenica; Slomovitz, Brian; Leitão, Mario M Jr; Baiocchi, Glauco

Normal Risk Ovarian Screening Study: 21-Year Update

正常风险卵巢筛查研究:21 年更新

Han, Chae Young; Lu, Karen H; Corrigan, Gwen; Perez, Alexandra; Kohring, Sharlene D; Celestino, Joseph; Bedi, Deepak; Bedia, Enrique; Bevers, Therese; Boruta, David; Carlson, Matthew; Holman, Laura; Leeds, Leroy; Mathews, Cara; McCann, Georgia; Moore, Richard G; Schlumbrecht, Matthew; Slomovitz, Brian; Tobias, Dan; Williams-Brown, Yvette; Bevers, Michael W; Liu, Jinsong; Gornet, Terrie G; Handy, Beverly C; Lu, Zhen; Bedia, Jacob S; Skates, Steven J; Bast, Robert C Jr

ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design

ENGOT-EN20/GOG-3083/XPORT-EC-042——一项III期、随机、安慰剂对照、双盲、多中心试验,评估塞利尼索在p53野生型、晚期或复发性子宫内膜癌患者系统治疗后维持治疗中的疗效:研究原理、方法和试验设计

Vergote, Ignace; Perez Fidalgo, Alejandro; Valabrega, Giorgio; Monk, Bradley J; Herzog, Thomas; Cibula, David; Colombo, Nicoletta; Pothuri, Bhavana; Sehouli, Jalid; Korach, Jacob; Barlin, Joyce; Papadimitriou, Christos A; van Gorp, Toon; Richardson, Debra; McCarthy, Michael; Antill, Yoland; Mirza, Mansoor Raza; Li, Kai; Kalyanapu, Pratheek; Slomovitz, Brian; Coleman, Robert L

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab

晚期子宫内膜癌患者接受乐伐替尼联合帕博利珠单抗治疗后不良反应的特征分析和管理

Colombo, Nicoletta; Lorusso, Domenica; Monk, Bradley J; Slomovitz, Brian; Hasegawa, Kosei; Nogueira-Rodrigues, Angélica; Zale, Melissa; Okpara, Chinyere E; Barresi, Gianmaria; McKenzie, Jodi; Makker, Vicky